Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Every dose is double what they think it is
It underscores the importance of cyclical protocols rather than continuous administration, allowing the body's insulin sensitivity to reset
A phase 2 trial published in the New England Journal of Medicine showed average weight loss of over 24% at 48 weeks, and the first phase 3 results in December 2025 suggested that average weight loss could be around 28 to 29%
Compound: CJC-1295 No DAC + Ipamorelin
[26] Enhanced Body Composition : Research suggests dihydroberberine may help preserve lean mass while promoting fat loss, a critical advantage over pharmaceutical options that can lead to muscle wasting
We also found that cord plasma from pregnancies with obesity induced transcriptional changes in hepatocytes that favor injury and inflammation and impair hepatocyte development compared to cord plasma of normal weight pregnancies
